Core Points - The company held its 18th meeting of the 4th Board of Directors on June 6, 2025, to discuss various resolutions related to board elections and company governance [1][2][3] Board Resolutions - The board approved the election of non-independent directors for the 5th Board, nominating five candidates: Yu Zizhou, Dong Xiaohong, Shi Yongbing, Hao Bin, and Lin Qing, with a unanimous vote of 9 in favor [1][2] - The board also approved the election of independent directors for the 5th Board, nominating three candidates: Xu Gaoyan, Yang Weicai, and Liang Lianhua, also with a unanimous vote of 9 in favor [2][3] - The qualifications of both non-independent and independent director candidates were reviewed and deemed compliant with relevant laws and regulations [2][3] Amendments and Capital Changes - The board proposed changes to the company's registered capital and amendments to the Articles of Association, which will require approval at the upcoming shareholder meeting [4][5] - The board also approved the revision and establishment of certain management systems to align with the latest legal requirements and improve governance [4][5] Investment Projects - The company plans to invest in an expansion project for its wholly-owned subsidiary, Huai'an Chenhua New Materials Co., Ltd., aiming for an annual production capacity of 35,000 tons of alkyl glycosides [5][6] Upcoming Shareholder Meeting - The board scheduled the 2025 First Extraordinary General Meeting for June 23, 2025, to discuss the aforementioned proposals and other matters [6]
晨化股份: 第四届董事会第十八次会议决议公告